Can losartan be taken every other day instead of once daily?

Losartan De-escalation to Every Other Day Dosing

No, losartan should not be taken every other day as a de-escalation strategy. Losartan is designed and FDA-approved for once-daily dosing, and every-other-day administration is not supported by pharmacokinetic data, clinical trials, or guideline recommendations 1.

Why Every-Other-Day Dosing Is Not Appropriate

Pharmacokinetic Considerations

• Losartan has a terminal half-life of approximately 2 hours, while its active metabolite (E-3174) has a half-life of 6-9 hours 1, 2
• These relatively short half-lives mean that every-other-day dosing would result in significant gaps in therapeutic coverage, with drug levels falling below effective concentrations between doses 2
• The pharmacokinetics are linear and dose-proportional with once-daily administration, but this relationship has not been studied with alternate-day dosing 1

FDA-Approved Dosing

• The FDA label explicitly states that losartan should be administered once daily, with dosing ranging from 25 mg to 100 mg daily 1
• For hypertension, the usual starting dose is 50 mg once daily, which can be increased to 100 mg once daily as needed 1
• If dose reduction is needed due to tolerability concerns, the appropriate approach is to decrease to 25 mg once daily, not to switch to alternate-day dosing 1

Guideline-Directed Approach to Dose Adjustment

For Heart Failure with Reduced Ejection Fraction (HFrEF)

• ACC/AHA guidelines emphasize titration to target doses (losartan 100 mg once daily, or 150 mg once daily per guidelines though FDA max is 100 mg) rather than dose reduction 3
• The target dose for losartan in HFrEF is 50-150 mg once daily, with clinical trials showing a mean achieved dose of 129 mg total daily 4, 5
• If target doses cannot be tolerated, the minimum acceptable approach is to maintain at least 50% of the target dose (50 mg once daily), not alternate-day dosing 3
• Dose adjustments should occur no more frequently than every 1-2 weeks based on symptoms, vital signs, and laboratory findings 4, 5

For Hypertension

• The 2025 AHA/ACC hypertension guidelines recommend once-daily dosing to improve medication adherence 6
• Losartan 50-100 mg once daily is the evidence-based regimen for blood pressure control 7, 6
• If blood pressure is controlled on a higher dose and reduction is desired, decrease to the next lower once-daily dose (e.g., from 100 mg to 50 mg daily), not to alternate-day dosing 7, 1

Proper De-escalation Strategy

If dose reduction is clinically indicated (e.g., hypotension, renal dysfunction, hyperkalemia), the correct approach is:

1. Reduce to the next lower once-daily dose (100 mg → 50 mg → 25 mg daily) 1
2. Monitor blood pressure and clinical status closely after any dose reduction 7, 6
3. For patients with hepatic impairment, start at 25 mg once daily 1
4. Consider switching to a different antihypertensive class if losartan cannot be tolerated at any once-daily dose 7, 6

Common Pitfalls to Avoid

• Do not confuse twice-daily dosing with every-other-day dosing: Some studies have examined losartan 50 mg twice daily versus 100 mg once daily, but this is fundamentally different from alternate-day administration 8, 9, 10
• Avoid arbitrary dose reductions without clinical indication: Guidelines emphasize achieving and maintaining target doses unless specific contraindications exist 11
• Do not discontinue or reduce doses based solely on asymptomatic hypotension or mild renal function changes: These often stabilize with continued therapy and can be managed with supportive measures 11

Evidence on Dosing Frequency

• Real-world data comparing twice-daily versus once-daily dosing showed no benefit to split dosing for blood pressure control 8
• Studies examining twice-daily administration used the same total daily dose split into two doses (e.g., 50 mg twice daily = 100 mg total daily), not alternate-day dosing 9, 10
• Ambulatory blood pressure monitoring demonstrates sustained 24-hour efficacy with once-daily dosing at appropriate doses 12, 10

If blood pressure or clinical status is well-controlled and dose reduction is desired, reduce to a lower once-daily dose rather than attempting every-other-day administration, which lacks any evidence base and would result in subtherapeutic drug levels.